Search results
Sanofi forecasts moderate profit growth on Dupixent demand
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool· 1 year agoIn the middle of December, Sanofi's (NASDAQ: SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGN)...
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
Motley Fool· 1 year agoLast month, Sanofi (NASDAQ: SNY) and Regeneron's (NASDAQ: REGN) immunology mega-blockbuster, known...
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2024 Earnings Call Apr 25, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoSanofi SNY will report third-quarter 2022 results on Oct 28 before market open. In the last reported...
Top Research Reports for Broadcom, Comcast & Equinor
Zacks via Yahoo Finance· 2 years agoWednesday, September 28, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new...
Stock-Split Watch: Could These 2 Market-Beaters Be Next?
Motley Fool via Yahoo Finance· 3 months agoFor moves that don't improve the underlying strength of a company's business, stock splits garner a...
Top Stock Reports for Amazon.com, Sanofi & Target
Zacks via Yahoo Finance· 1 year agoFriday, November 11, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research...
Dow Jones, Financial Stocks Climb Off Lows Despite Economic Jitters; Baidu, ELF Beauty Show Strength
Investor's Business Daily· 1 year agoAfter two straight bearish reversals off highs, sellers knocked the Dow Jones Industrial Average and...
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
Motley Fool via Yahoo Finance· 3 months agoThe stock market has given investors plenty to talk about over the last few years, and those who have stayed in it through the ups and downs have dealt...